Conscience Issue Tracker - December 2024

Conscience Issue Tracker - December 2024 Issues in this edition: President-Elect Trump Appoints FDA and NIH Directors PREVAIL Act Narrowly Moves Forward Despite Concerns About Drug Pricing Impact EQBMED launches trial sites tool to assess performance and boost diversity Canadian Intellectual Property Office (CIPO) Releases 2024 Report

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-11
DOI
https://doi.org/10.5281/zenodo.14373074
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Conscience Issue Tracker - December 2024

Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Economics and Policy
article

Conscience Issue Tracker - December 2024

article en

Abstract

Conscience Issue Tracker - December 2024 Issues in this edition: President-Elect Trump Appoints FDA and NIH Directors PREVAIL Act Narrowly Moves Forward Despite Concerns About Drug Pricing Impact EQBMED launches trial sites tool to assess performance and boost diversity Canadian Intellectual Property Office (CIPO) Releases 2024 Report

Zenodo (CERN European Organization for Nuclear Research)
McGill University (CA)
Openalex Percentile: Top 50%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Conscience Issue Tracker - December 2024 · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS